Sialic Acids in the Immune Response during Sepsis

Area of Science:

• Immunology
• Molecular Biology
• Pathology

Background:

• Sialic acid-binding immunoglobulin-type lectins (Siglecs) are cell surface receptors on immune cells.
• Siglecs play crucial roles in regulating immune balance and inflammatory responses.
• Sepsis is a life-threatening condition characterized by immune dysregulation, inflammation, and coagulation disorders.

Purpose of the Study:

• To review the diverse roles of the Siglec family in the pathogenesis of sepsis.
• To elucidate how Siglecs modulate inflammation, immunity, and cellular functions during sepsis.
• To explore the therapeutic potential of targeting Siglec functions in sepsis.

Main Methods:

• Literature review of Siglec family roles in sepsis pathogenesis.
• Analysis of Siglec-mediated modulation of immune cells and inflammatory pathways.
• Examination of Siglec interactions with key sepsis-related molecules and receptors.

Main Results:

• Siglec-1, Siglec-5, and Siglec-14 exhibit bidirectional roles in modulating inflammation and immunity.
• Siglec-2 influences immune balance by regulating B cell and T cell responses during infection.
• Siglec-9 and Siglec-10 demonstrate specific functions in regulating TLR4 endocytosis, macrophage polarization, neutrophil function, and inflammation.

Conclusions:

• The Siglec family plays multifaceted roles in sepsis pathogenesis.
• Specific Siglecs like Siglec-9 and Siglec-10 have distinct immunomodulatory functions relevant to sepsis.
• Targeting Siglec pathways presents a promising avenue for novel sepsis therapies.